MELT-300, a non-IV, non-opioid sedation tablet, showed positive Phase 3 results for cataract surgery, supporting FDA ...

Melt Pharmaceuticals has reported encouraging topline results from its Phase III trial of MELT-300, a non-intravenous, ...

Cataract surgery is one of the oldest surgical procedures ... [13] The advent of topical anesthesia made this procedure more practical. The early techniques involved removing the entire opaque ...

non-opioid alternative to current IV-based cataract surgery sedation protocols, which generally involve the administration of opioids,” said Dr Larry Dillaha, Chief Executive Officer of Melt.

Melt Pharmaceuticals announced positive topline results of its pivotal Phase 3 study evaluating the safety and efficacy of its lead product ...

Cataract surgery nowadays is a day-care procedure which is totally painless. It’s routinely done under topical anesthesia, done with eye drops and does not involve any injection around the eye.

Melt Pharmaceuticals has reported encouraging topline results from its Phase III trial of MELT-300, a non-intravenous, non-opioid sedation tablet for cataract surgery. The pivotal study's design ...

Cataract surgery is one of the most popular and commonly performed procedures in the world. The vast majority of patients ...

The trial involved over 530 patients across 13 US clinical sites. Credit: Lucky Business/Shutterstock. Melt Pharmaceuticals has reported encouraging topline results from its Phase III trial of ...

a non-IV, non-opioid tablet for procedural sedation during cataract surgery. Based on a Special Protocol Assessment agreement reached with the U.S. Food and Drug Administration earlier this year ...